BiOligo Biotechnology

Technology · Website

Portfolio company of The Carlyle Group, Washington, D.C., U.S..

ExitedTechnology

Overview

BiOligo Biotechnology is a technology portfolio company held by The Carlyle Group, with parent firm headquartered in Washington, D.C., U.S.. Profile compiled from public sources; submit updates to extend the public record.

Parent PE firmThe Carlyle Group

SectorTechnology

Ownership statusExited

WebsiteVisit ↗

Source

http://carlyle.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with BiOligo Biotechnology and does not provide investment advice.